Isosorbide Mononitrate Tablet, Extended Release
Product Images NDC 51655-922

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Isosorbide Mononitrate (NDC 51655-922). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (1672236d 6141 41be B457 0fe597cf0171 01)

Structure (1672236d 6141 41be B457 0fe597cf0171 01)
Chemical structure of Isosorbide Mononitrate as shown in the drawing, depicting its molecular connectivity and arrangement.*
FDA Label Image

Ingenus Logo (1672236d 6141 41be B457 0fe597cf0171 02)

FDA Label Image

Label (51655 922 52 Master Bottle Label Approval Rev A 03 22)

Label (51655 922 52 Master Bottle Label Approval   Rev A 03 22)
Label for Isosorbide Mononitrate Extended-Release Tablets, USP 30 mg, oral dosage form. The label shows a package containing 30 tablets with storage instructions at 20°-30°C, and notes RX only status. The labeler is Northwind Health Company, LLC, and it includes packaging and lot information with NDC 51655-922-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.